ENXTPA:SANPharmaceuticals
Sanofi Expands Alzheimer’s And Vaccine Efforts As Valuation Gap Widens
Sanofi joined the expanded Bio-Hermes-002 Alzheimer’s biomarker study, a global collaboration focused on next generation blood based and digital diagnostics.
The company also reported progress in its vaccine portfolio, supported by the acquisition of a hepatitis B shot.
These developments highlight activity in neurodegenerative disease research and vaccines that has not been widely discussed recently.
For investors watching ENXTPA:SAN, the news comes at a time when the stock trades around...